Providence Medical Technology (PMT) has concluded patient enrolment in its study of the Posterior Cervical Stabilisation System (PCSS).
The prospective, multicentre, randomised, investigational device exemption FUSE Study is intended to assess the safety and effectiveness of PCSS in three-level cervical fusion patients.
PMT has enrolled around 230 patients across 18 US spinal surgery sites to assess PCSS along with Anterior Cervical Discectomy and Fusion (ACDF) compared to ACDF alone in a superiority study.
